We evaluated the relationship between IGFLR1 expression level and overall survival (OS), disease free survival (DFS) of ccRCC patients via “Survival” module in GEPIA, respectively. This evidence concerns the gene IGFLR1 and nonpapillary renal cell carcinoma.